Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Nanomolar Potency Aminophenyltriazine CFTR Activator Reverses Corneal Epithelial Injury in a Mouse Model of Dry Eye

Journal of Ocular Pharmacology and Therapeutics(2020)10.1089/jop.2019.0087Source: DataRank Database

Nanomolar Potency Aminophenyltriazine CFTR Activator Reverses Corneal Epithelial Injury in a Mouse Model of Dry Eye is a research paper published in Journal of Ocular Pharmacology and Therapeutics (2020). On theSindex it has a DataRank of 0. It has been cited 20 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access20 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 1.54)OA: bronzeTopics (63)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Sujin Lee ORCID,Tianyi Zhang ORCID,Tianying Duan,Neel D. Pasricha ORCID,Julie M. Schallhorn ORCID

Live enrichment

PubMed:31934802 PMC:PMC7175624 OpenAlex:https://openalex.org/W3000017633

NIDDK NIH HHS

Grant: P30 DK072517

NIDDK NIH HHS

Grant: R01 DK101373

NEI NIH HHS

Grant: R01 EY013574

FWCI

1.54

Citation Percentile

0.8%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

bronzeLicense: https://journals.sagepub.com/page/policies/text-and-data-mining-license

journalhttps://www.liebertpub.com/doi/pdf/10.1089/jop.2019.0087

publisherhttps://www.liebertpub.com/doi/pdf/10.1089/jop.2019.0087

publisherhttps://journals.sagepub.com/doi/full-xml/10.1089/jop.2019.0087

publisherhttps://journals.sagepub.com/doi/pdf/10.1089/jop.2019.0087

journalhttps://doi.org/10.1089/jop.2019.0087

Fields of Study

Ocular Surface and Contact LensAllergic Rhinitis and SensitizationAdvanced Drug Delivery SystemsAdministration, TopicalAnimalsBenzoatesCauteryChloride ChannelsCorneal InjuriesCystic Fibrosis Transmembrane Conductance RegulatorDisease Models, AnimalDry Eye SyndromesFemaleLacrimal ApparatusLissamine Green DyesMiceMice, Inbred BALB CNanotechnologyTearsThiazolidinesTreatment OutcomeTriazines

MeSH Terms

Administration, TopicalAnimalsBenzoatesCauteryDisease Models, AnimalFemaleLacrimal ApparatusLissamine Green DyesMice, Inbred BALB CTearsTriazinesDry Eye SyndromesTreatment OutcomeChloride ChannelsCystic Fibrosis Transmembrane Conductance RegulatorNanotechnologyMiceThiazolidinesCorneal Injuries

Keywords

Cystic fibrosis transmembrane conductance regulatorIn vivoCorneaMedicineCorneal epitheliumPotencyTransepithelial potential differenceOphthalmologyPharmacologyPharmacokineticsCystic fibrosisChemistryPathologyIn vitroInternal medicineBiologyBiochemistryIon transporterChloride channelCftrKeratoconjunctivitis SiccaLacrimal Duct Cautery

Sustainable Development Goals

SDG 0: Good health and well-being